Catalyst Wire Dossier Catalyst Wire Dossier

budesonide orodispersible tablets

budesonide · Dr. Falk Pharma GmbH
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for budesonide orodispersible tablets, covering 2021-10-07 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE [Phase 3]

See pricing